Toxicological and public good considerations for the regulation of nanomaterial-containing medical products
about
Responses of human cells to ZnO nanoparticles: a gene transcription study.Advanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging.Liposomes in drug delivery: a patent review (2007 - present).Governing Planetary Nanomedicine: Environmental Sustainability and a UNESCO Universal Declaration on the Bioethics and Human Rights of Natural and Artificial Photosynthesis (Global Solar Fuels and Foods)
P2860
Toxicological and public good considerations for the regulation of nanomaterial-containing medical products
description
im März 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 March 2008
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2008
@uk
name
Toxicological and public good ...... al-containing medical products
@en
Toxicological and public good ...... al-containing medical products
@nl
type
label
Toxicological and public good ...... al-containing medical products
@en
Toxicological and public good ...... al-containing medical products
@nl
prefLabel
Toxicological and public good ...... al-containing medical products
@en
Toxicological and public good ...... al-containing medical products
@nl
P2860
P356
P1476
Toxicological and public good ...... al-containing medical products
@en
P2093
Thomas A Faunce
P2860
P304
P356
10.1517/14740338.7.2.103
P407
P577
2008-03-01T00:00:00Z